NATCOPHARM

Natco Pharma Share PriceNatco Pharma

₹555.7
4.6 (0.83%)
As on 30 March, 2023 | 13:30 BSE: 524816 NSE: NATCOPHARM

Natco Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Natco Pharma

Start SIP

Natco Pharma Share Price

  • Over 1 Month 3.3%
  • Over 3 Month -0.22%
  • Over 6 Month -9.58%
  • Over 1 Year -28.45%

Natco Pharma Key Statistics

P/E Ratio 26.1
PEG Ratio 0.6
Market Cap Cr 10,145
Price to Book Ratio 2.4
EPS 5.8
Dividend 1
Relative Strength Index 56.68
Money Flow Index 67.5
MACD Signal 0.66
Average True Range 14.22

Natco Pharma Investment Rating

  • Master Rating:
  • Natco Pharma has an operating revenue of Rs. 2,406.00 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 10% is healthy, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Natco Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 413351806514
Operating Expenses Qtr Cr 346281426552
Operating Profit Qtr Cr 6870379-38
Depreciation Qtr Cr 38383736
Interest Qtr Cr 3234
Tax Qtr Cr 8965-6
Net Profit Qtr Cr 3738308-61

Natco Pharma Technicals

EMA & SMA

Current Price
₹555.7
4.6 (0.83%)
  • Bullish Moving Average
  • ___
  • 12
  • Bearish Moving Average
  • ___
  • 4
  • 20 Day
  • 545.79
  • 50 Day
  • 546.76
  • 100 Day
  • 561.19
  • 200 Day
  • 606.68
  • 20 Day
  • 548.09
  • 50 Day
  • 540.24
  • 100 Day
  • 553.75
  • 200 Day
  • 595.35

Natco Pharma Resistance and Support

PIVOT
₹552.82
Resistance
First Resistance 560.79
Second Resistance 570.47
Third Resistance 578.44
RSI 56.68
MFI 67.5
MACD Single Line 0.66
MACD 1.44
Support
First Resistance 543.14
Second Resistance 535.17
Third Resistance 525.49

Natco Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 693,097 51,621,865 74.48
Week 332,197 22,489,737 67.7
1 Month 405,085 25,901,107 63.94
6 Month 276,029 16,432,022 59.53

Natco Pharma Result Highlights

Natco Pharma Synopsis

NSE-Medical-Diversified

Natco Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1767.80 Cr. and Equity Capital is Rs. 36.50 Cr. for the Year ended 31/03/2022. Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201.
Market Cap 10,145
Sales 2,084
Shares in Float 9.31
No of funds 210
Yield 0.99
Book Value 2.42
U/D Vol ratio 1.3
LTDebt / Equity
Alpha -0.11
Beta 0.5

Natco Pharma

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 48.82%48.8%48.8%
Mutual Funds 8.18%7.63%6.75%
Insurance Companies 6.18%6.07%
Foreign Portfolio Investors 11.73%11.67%11.65%
Financial Institutions/ Banks
Individual Investors 19.83%20.14%18.45%
Others 5.26%5.69%14.35%

Natco Pharma Management

Name Designation
Mr. V C Nannapaneni Managing Director
Mr. Rajeev Nannapaneni Director & CEO
Mr. T V Rao Independent Director
Mr. G S Murthy Chairman & Ind.Director
Mr. D G Prasad Independent Director
Dr. M U R Naidu Independent Director
Dr. Leela Digumarti Independent Director
Mr. P S R K Prasad Director & Exe. VP (Corp. Engg. Services)
Dr. Linga Rao Donthineni Director & President (Tech. Affairs)
Mr. Pavan Bhat Director

Natco Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Natco Pharma MF Shareholding

Name Amount(cr)
ICICI Prudential Value Discovery Fund Growth 27450
Mirae Asset Emerging Bluechip Fund Growth 23394
Mirae Asset Midcap Fund Regular Growth 8754
SBI Magnum Midcap Fund Regular Growth 8436
ICICI Prudential India Opportunities Fund Regular Growth 7644

Natco Pharma FAQs

What is Share Price of Natco Pharma ?

Natco Pharma share price is ₹555 As on 30 March, 2023 | 13:16

What is the Market Cap of Natco Pharma ?

The Market Cap of Natco Pharma is ₹10144.7 Cr As on 30 March, 2023 | 13:16

What is the P/E ratio of Natco Pharma ?

The P/E ratio of Natco Pharma is 26.1 As on 30 March, 2023 | 13:16

What is the PB ratio of Natco Pharma ?

The PB ratio of Natco Pharma is 2.4 As on 30 March, 2023 | 13:16

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number